Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 24 December 2004:
Vol. 306. no. 5705, p. 2173
DOI: 10.1126/science.306.5705.2173c
Prev | Table of Contents | Next

ScienceScope

A battle with intestinal cancer has convinced a retiring U.S. lawmaker to take a lucrative job as a drug industry lobbyist that he was up for earlier this year.

Representative Billy Tauzin (R-LA) was rumored to be in line for the job as president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA) before critics said his role in negotiating a new Medicare prescription law posed a conflict of interest (Science, 6 February, 2004, p. 761). Tauzin, 61, said he did not negotiate with PhRMA while handling the drug bill, but that being a patient for most of the year inspired him to take the PhRMA job. He assumes the post on 3 January.




To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)